13F reference period
Q2 2026
Security Snapshot
LifeStance Health Group, Inc. - Common Stock (LFST) Institutional Ownership
CUSIP: 53228F101
13F Institutional Holders and Ownership History from Q2 2021 to Q3 2026
Institutions Reporting
287
Shares (Excl. Options)
375.75M
Full value: 375,751,327 · shares · 30 Jun 2026Price
$10.71
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- LFST on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 375,751,327
- Total 13F value
- $4,023,241,727
- Portfolio coverage rank
- 0.01%
- Share change
- +7,104,170
- Value change
- +$110,608,811
- Number of holders
- 287
- Shares outstanding
- 382,903,990
- SEC-reported price per share
- $12.22
- Insider filing price
- $12.22
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- LFST - LifeStance Health Group, Inc. - Common Stock is tracked under CUSIP 53228F101.
- 287 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 228 to 287 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$2.35B
Full value: $2,348,160,925 · USD · 31 Mar 2026.$4.02B
Full value: $4,023,241,727 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 287 institutions filings for Q2 2026.
Security key
53228F101
13F reference period
Q2 2026
13F holders
287
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
LFST full holder history
LifeStance Health Group, Inc. SEC filings
LifeStance Health Group, Inc. company facts
LifeStance Health Group, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 53228F101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
LFST
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 26% | -12% | $1,105,602,857 | -$153,758,943 | 98,101,407 | -12% | TPG GP A, LLC | 30 Jun 2026 |
| FMR LLC | 15% | +25% | $372,437,846 | +$74,915,634 | 58,467,480 | +25% | FMR LLC | 31 Mar 2026 |
| BlackRock, Inc. | 10% | +22% | $488,057,084 | +$83,782,148 | 38,673,303 | +21% | BlackRock, Inc. | 30 Sep 2026 |
| SUMMIT PARTNERS L P | 6.1% | -20% | $262,704,996 | -$66,489,179 | 23,310,115 | -20% | Summit Partners, L.P. | 30 Jun 2026 |
As of 30 Jun 2026,
287
institutional investors reported holding
shares of
LifeStance Health Group, Inc. - Common Stock (LFST).
This represents
98%
of the company’s total
outstanding shares.
375.75M
Full value: 375,751,327 · shares · 30 Jun 2026382.9M
Full value: 382,903,990 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
87%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| TPG GP A, LLC | 29% | 111,744,614 | -20% | 24% | $1,196,784,816 |
| FMR LLC | 15% | 58,252,466 | -0.74% | 0.03% | $623,883,915 |
| BlackRock, Inc. | 9.5% | 36,348,507 | +100% | 0.01% | $389,292,501 |
| SUMMIT PARTNERS L P | 6.1% | 23,310,115 | -20% | 41% | $249,651,332 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6% | 13,960,892 | +44% | 0.01% | $149,521,153 |
| JENNISON ASSOCIATES LLC | 3.2% | 12,077,557 | +18% | 0.08% | $129,350,637 |
| DIMENSIONAL FUND ADVISORS LP | 3% | 11,427,602 | +10% | 0.02% | $122,376,500 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5% | 9,735,076 | +23% | 0% | $104,262,664 |
| STATE STREET CORP | 2.1% | 8,228,351 | +101% | 0% | $88,125,639 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.6% | 5,947,600 | -2.4% | 0.01% | $63,698,796 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 5,592,598 | +18% | 0% | $59,909,776 |
| MORGAN STANLEY | 1.3% | 5,021,527 | +46% | 0% | $53,780,555 |
| PRINCIPAL FINANCIAL GROUP INC | 1% | 3,996,866 | +30% | 0.02% | $42,806,433 |
| MILLENNIUM MANAGEMENT LLC | 0.94% | 3,606,755 | +90% | 0.03% | $38,628,346 |
| Nuveen, LLC | 0.8% | 3,061,724 | +38% | 0.01% | $32,791,064 |
| Integral Health Asset Management, LLC | 0.78% | 3,000,000 | -30% | 1.3% | $32,130,000 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.75% | 2,883,371 | 0.01% | $30,880,903 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.72% | 2,769,327 | +1751% | 0% | $29,660,000 |
| NORTHERN TRUST CORP | 0.56% | 2,137,906 | +39% | 0% | $22,896,974 |
| Woodline Partners LP | 0.54% | 2,068,445 | +14% | 0.07% | $22,153,046 |
| BARCLAYS PLC | 0.54% | 2,054,414 | -26% | 0.01% | $22,002,775 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.52% | 1,979,078 | +28% | 0% | $21,195,925 |
| MACKENZIE FINANCIAL CORP | 0.51% | 1,967,647 | 0.02% | $21,073,499 | |
| LOOMIS SAYLES & CO L P | 0.49% | 1,882,750 | +12% | 0.03% | $20,164,253 |
| GOLDMAN SACHS GROUP INC | 0.47% | 1,811,778 | -13% | 0% | $19,404,143 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
22
Headline period
Q2 2026
Rows shown
1-22 of 22
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 21,332,535 | $256,589,866 | -$71,453,953 | $12.03 | 87 |
| 2026 Q2 | 375,751,327 | $4,023,241,727 | +$110,608,811 | $10.71 | 287 |
| 2026 Q1 | 368,584,899 | $2,348,160,925 | -$41,824,675 | $6.37 | 228 |
| 2025 Q4 | 373,840,439 | $2,631,720,829 | +$79,141,014 | $7.04 | 204 |
| 2025 Q3 | 349,969,140 | $1,924,816,649 | +$2,242,263 | $5.50 | 208 |
| 2025 Q2 | 349,211,507 | $1,805,446,226 | +$26,470,202 | $5.17 | 193 |
| 2025 Q1 | 343,293,098 | $2,286,399,131 | +$28,506,338 | $6.66 | 180 |
| 2024 Q4 | 336,632,306 | $2,481,009,214 | +$57,920,008 | $7.37 | 152 |
| 2024 Q3 | 328,987,104 | $2,302,787,638 | +$385,503 | $7.00 | 129 |
| 2024 Q2 | 327,111,787 | $1,606,123,781 | +$26,316,859 | $4.91 | 130 |
| 2024 Q1 | 321,255,679 | $1,982,331,016 | +$72,312,533 | $6.17 | 123 |
| 2023 Q4 | 309,497,893 | $2,423,368,969 | +$91,163,728 | $7.83 | 118 |
| 2023 Q3 | 298,420,193 | $2,050,146,379 | +$48,948,530 | $6.87 | 117 |
| 2023 Q2 | 290,988,403 | $2,656,744,574 | +$31,775,791 | $9.13 | 109 |
| 2023 Q1 | 287,568,675 | $2,136,617,078 | +$2,802,644 | $7.43 | 86 |
| 2022 Q4 | 287,897,858 | $1,422,185,198 | -$5,682,633 | $4.94 | 84 |
| 2022 Q3 | 288,807,286 | $1,911,997,521 | -$30,576,662 | $6.62 | 72 |
| 2022 Q2 | 294,731,958 | $1,638,707,002 | +$20,710,430 | $5.56 | 76 |
| 2022 Q1 | 290,691,955 | $2,938,605,431 | +$156,460,286 | $10.11 | 72 |
| 2021 Q4 | 275,145,168 | $2,619,339,115 | -$24,317,438 | $9.52 | 62 |
| 2021 Q3 | 275,121,437 | $3,989,223,790 | -$38,569,110 | $14.50 | 68 |
| 2021 Q2 | 270,204,603 | $7,528,083,656 | +$7,528,083,616 | $27.86 | 81 |